Singleton Merten syndrome
Singleton Merten syndrome is a rare genetic disorder characterized by a combination of dental anomalies, osteoporosis, and calcification of the aorta and heart valves. The syndrome was first described by Singleton and Merten in 1973.
Presentation[edit | edit source]
Individuals with Singleton Merten syndrome typically present with a variety of symptoms, including:
- Severe periodontitis leading to early loss of teeth
- Osteoporosis and osteopenia
- Aortic valve and mitral valve calcification
- Muscle weakness
- Growth retardation
- Joint pain and arthritis
Genetics[edit | edit source]
Singleton Merten syndrome is inherited in an autosomal dominant manner. Mutations in the IFIH1 gene have been identified as a cause of the syndrome. The IFIH1 gene is involved in the body's immune response to viral infections.
Diagnosis[edit | edit source]
Diagnosis of Singleton Merten syndrome is based on clinical evaluation, family history, and genetic testing. Imaging studies such as X-rays and echocardiograms are used to assess bone density and heart valve calcification.
Management[edit | edit source]
There is no cure for Singleton Merten syndrome, and treatment is primarily supportive. Management may include:
- Dental care to manage periodontitis
- Bisphosphonates to treat osteoporosis
- Regular monitoring of heart function
- Physical therapy to improve muscle strength and joint function
Prognosis[edit | edit source]
The prognosis for individuals with Singleton Merten syndrome varies depending on the severity of symptoms and the presence of complications such as heart valve calcification. Early diagnosis and management can improve quality of life.
Related Pages[edit | edit source]
- Genetic disorder
- Periodontitis
- Osteoporosis
- Aortic valve
- Mitral valve
- Autosomal dominant
- Genetic testing
- Bisphosphonates
- Physical therapy
Categories[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD